# US 2013/0157877 A1 · Biochips for analyzing nucleic acid molecule dynamics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157877 A1
- Document ID: US20130157877A1
- Status: Published application
- Kind: A1
- Application number: 13/819,664
- Filed: 2011-09-01
- Published: 2013-06-20
- Earliest claimed: 2010-09-03
- Assignees: Institut National Des Sciences Appliquees De Toulouse; Centre National de la Recherche Scientifique (CNRS)
- Inventors: Thomas Plenat; Laurence Salome; Catherine Tardin; Christophe Thibault; Emmanuelle Trevisiol; Christophe Vieu
- Web page: https://patentgrep.com/patent/US20130157877A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to biochips 1 comprising a substrate 2, wherein said substrate comprises at the surface thereof isolated regions 3 for the anchoring of a nucleic acid molecule, said isolated regions having an area of less than 1 μm2, and the space 4 between two isolated regions being at least equal to the square root of the value of said area of said isolated regions.

## Claims

### Claim 1

A biochip comprising a substrate, said substrate comprising at its surface isolated regions for the anchoring of a nucleic acid molecule, said isolated regions having an area of less than 1 μm2, and the space between two isolated regions being at least equal to the square root of the value of said area of said isolated regions.

### Claim 2 (depends on 1)

The biochip as claimed in claim 1, characterized in that said isolated regions have a layer of molecules for the anchoring of a nucleic acid molecule.

### Claim 3 (depends on 2)

The biochip as claimed in claim 2, characterized in that said molecules for the anchoring of a nucleic acid molecule are chosen from streptavidin; avidin; streptavidin derivatives and avidin derivatives, in particular neutravidin; antibodies, in particular anti-digoxigenin, anti-BSA and anti-carboxyfluorescein antibodies; oligonucleotides or functionalized oligonucleotides.

### Claim 4 (depends on 1)

The biochip as claimed in claim 1, characterized in that each isolated region enables the anchoring only of a single nucleic acid molecule.

### Claim 5 (depends on 1)

The biochip as claimed in claim 1, characterized in that said substrate is chosen from an inorganic substrate; an organic substrate, in particular a polymer substrate; and a metal substrate.

### Claim 6 (depends on 1)

The biochip as claimed in claim 1, characterized in that said substrate is a glass coverslip functionalized with epoxides, or a glass coverslip functionalized with a PEG/PEG-biotin mixture.

### Claim 7 (depends on 1)

The biochip as claimed in claim 1, characterized in that said isolated regions have an area of less than or equal to 0.9 μm2, 0.8 μm2, 0.7 μm2, 0.6 μm2, 0.5 μm2, 0.4 μm2, 0.3 μm2, 0.2 μm2, 0.1 μm2, 0.09 μm2, 0.07 m2, 0.05 μm2 or 0.04 μm2.

### Claim 8 (depends on 1)

The biochip as claimed in claim 1, characterized in that said isolated regions have a square shape with a side of less than 1 μm, particularly less than or equal to 900 nm, 800 nm, 700 nm, 600 nm, 500 nm, 400 nm, 300 nm, or more particularly less than or equal to 200 nm.

### Claim 9 (depends on 1)

The biochip as claimed in claim 1, characterized in that each isolated region enables the anchoring of a single nucleic acid molecule, the characteristic dimension of said nucleic acid molecule being greater than half the square root of the value of the area of the isolated region on which said nucleic acid molecule is attached.

### Claim 10 (depends on 1)

The biochip as claimed in claim 1, characterized in that it also comprises a coverslip positioned above the substrate, said coverslip comprising at least two openings for the introduction of solutions at the level of the isolated regions, the whole assembly defining an observation chamber.

### Claim 11

A process for fabricating a biochip, comprising the following steps:
(a) providing a substrate, and
(b) printing on said substrate isolated regions for the anchoring of a nucleic acid molecule, said isolated regions having an area of less than 1 μm2, and the space between two isolated regions being at least equal to the square root of the value of said area of said isolated regions.

### Claim 12 (depends on 11)

The process as claimed in claim 11, characterized in that step (b) consists in printing on the substrate, in said isolated regions, a layer of molecules for the anchoring of a nucleic acid molecule.

### Claim 13 (depends on 12)

The process as claimed in claim 12, characterized in that, before step (b), the substrate is treated so as to attach said molecules for the anchoring of a nucleic acid molecule.

### Claim 14 (depends on 11)

The process as claimed in claim 11, characterized in that step (b) is carried out according to the microcontact printing, “lite-off” or “inverted print” method.

### Claim 15 (depends on 1, 2)

A process for studying nucleic acid molecules using the “Tethered Particle Motion” or “TPM” technique, comprising the steps of:
1) providing a biochip as defined in claim 1,
2) treating the nucleic acid molecules so as, on the one hand, to be able to attach them to the biochip and, on the other hand, to be able to analyze them using the “Tethered Particle Motion” or “TPM” technique,
3) studying the nucleic acid molecules using the “Tethered Particle Motion” or “TPM” technique.

### Claim 16 (depends on 15)

The process as claimed in claim 15, characterized in that the characteristic dimension of said nucleic acid molecules is greater than half the square root of the value of the area of said isolated regions of the biochip.

### Claim 17 (depends on 1)

A kit comprising:
a biochip as defined in claim 1, and
a computer-readable medium comprising instructions which can be executed by said computer in order to implement a process, the process comprising:
1) providing the biochip;
2) treating the nucleic acid molecules so as, on the one hand, to be able to attach them to the biochip and, on the other hand, to be able to analyze them using the “Tethered Particle Motion” or “TPM” technique; and
3) studying the nucleic acid molecules using the “Tethered Particle Motion” or “TPM” technique.

### Claim 18 (depends on 1)

The use of a biochip as defined in claim 1 for studying nucleic acid molecules using the “Tethered Particle Motion” or “TPM” technique.

### Claim 19 (depends on 18)

The use as claimed in claim 18, characterized in that the characteristic dimension of said nucleic acid molecules is greater than half the square root of the value of the area of said isolated regions of the biochip.
